EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.
Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Antón J, Belot A, Bracaglia C, Constantin T, Dagna L, Di Bartolo A, Feist E, Foell D, Gattorno M, Georgin-Lavialle S, Giacomelli R, Grom AA, Jamilloux Y, Laskari K, Lazar C, Minoia F, Nigrovic PA, Oliveira Ramos F, Ozen S, Quartier P, Ruscitti P, Sag E, Savic S, Truchetet ME, Vastert SJ, Wilhelmer TC, Wouters C, Carmona L, De Benedetti F.
Ann Rheum Dis. 2024 Nov 14;83(12):1614-1627. doi: 10.1136/ard-2024-225851.
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P.
Semin Arthritis Rheum. 2021 Aug;51(4):858-874. doi: 10.1016/j.semarthrit.2021.06.004. Epub 2021 Jun 13.
Adult-Onset Still's Disease: Clinical Aspects and Therapeutic Approach.
Tomaras S, Goetzke CC, Kallinich T, Feist E.
J Clin Med. 2021 Feb 12;10(4):733. doi: 10.3390/jcm10040733.
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease.
De Matteis A, Bindoli S, De Benedetti F, Carmona L, Fautrel B, Mitrovic S.
Ann Rheum Dis. 2024 Nov 14;83(12):1748-1761. doi: 10.1136/ard-2024-225853.
Adult-onset Still's disease.
van de Putte LB, Wouters JM.
Baillieres Clin Rheumatol. 1991 Aug;5(2):263-75. doi: 10.1016/s0950-3579(05)80283-3.
Recent advances and evolving concepts in Still's disease.
Ruscitti P, Cantarini L, Nigrovic PA, McGonagle D, Giacomelli R.
Nat Rev Rheumatol. 2024 Feb;20(2):116-132. doi: 10.1038/s41584-023-01065-6. Epub 2024 Jan 11.
Activation mechanisms of monocytes/macrophages in adult-onset Still disease.
Tsuboi H, Segawa S, Yagishita M, Toko H, Honda F, Kitada A, Miki H, Ohyama A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.
Front Immunol. 2022 Aug 26;13:953730. doi: 10.3389/fimmu.2022.953730. eCollection 2022.
Adult-onset Still disease.
Fautrel B.
Best Pract Res Clin Rheumatol. 2008 Oct;22(5):773-92. doi: 10.1016/j.berh.2008.08.006.
Canakinumab for Adult-Onset Still Disease: CADTH Health Technology Review.
Authors; Tran K, Mierzwinski-Urban M.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar. Report No.: RC1475.
Canakinumab for the treatment of adult-onset Still's disease.
Sfriso P, Bindoli S, Doria A, Feist E, Galozzi P.
Expert Rev Clin Immunol. 2020 Feb;16(2):129-138. doi: 10.1080/1744666X.2019.1707664. Epub 2020 Jan 18.
